PDCD1 and neoplasm: PD-1 expresses increasingly on the surface of activated T cells, while tumor cells could induce immune suppression by upregulating its ligand PD-L1 expression, and the combination of PD-1 and PD-L1 could inhibit the antitumor effect of T cells (11).